Autoriseret fysioterapeut Boe ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 0.6% 0.7%  
Credit score (0-100)  0 0 0 96 94  
Credit rating  N/A N/A N/A A A  
Credit limit (kDKK)  0.0 0.0 0.0 3,079.5 3,396.3  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 7,099 8,765  
EBITDA  0.0 0.0 0.0 4,098 5,790  
EBIT  0.0 0.0 0.0 1,512 3,140  
Pre-tax profit (PTP)  0.0 0.0 0.0 1,489.8 3,298.1  
Net earnings  0.0 0.0 0.0 1,150.7 2,574.7  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 1,490 3,298  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 3,697 3,666  
Shareholders equity total  0.0 0.0 0.0 30,362 32,437  
Interest-bearing liabilities  0.0 0.0 0.0 4,500 4,500  
Balance sheet total (assets)  0.0 0.0 0.0 42,894 47,044  

Net Debt  0.0 0.0 0.0 1,179 -5,308  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 7,099 8,765  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 23.5%  
Employees  0 0 0 4 4  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 42,894 47,044  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% 9.7%  
Added value  0.0 0.0 0.0 1,512.2 5,790.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 34,361 -4,432  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 1.0 2.0  

Profitability 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 21.3% 35.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% 4.3% 10.1%  
ROI %  0.0% 0.0% 0.0% 4.4% 10.7%  
ROE %  0.0% 0.0% 0.0% 3.8% 8.2%  

Solidity 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% 0.0% 70.8% 68.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 28.8% -91.7%  
Gearing %  0.0% 0.0% 0.0% 14.8% 13.9%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 15.1% 27.3%  

Liquidity 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.0 1.0 1.5  
Current Ratio  0.0 0.0 0.0 1.0 1.5  
Cash and cash equivalent  0.0 0.0 0.0 3,320.6 9,807.9  

Capital use efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 -3,266.1 -4,652.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 378 1,448  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 1,025 1,448  
EBIT / employee  0 0 0 378 785  
Net earnings / employee  0 0 0 288 644